Longer-Term Effects of Remote Patient Management Following Hospital Discharge After Acute Systolic Heart Failure: The Randomized E-INH Trial

Longer-Term Effects of Remote Patient Management Following Hospital Discharge After Acute Systolic Heart Failure: The Randomized E-INH Trial Background: The randomized INH (Interdisciplinary Network Heart Failure) trial (N = 715) reported that 6 months' remote patient management (RPM) (HeartNetCare-HF) did not reduce the primary outcome (time to all-cause death/rehospitalization) vs usual care (UC) in patients discharged [...]

2023-02-22T15:33:31-04:00January 11th, 2023|

Heart Failure Drug Treatment-Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF)

Heart Failure Drug Treatment-Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF) Background: Guidelines recommend early initiation of multiple guideline-directed medical therapies (GDMTs) to reduce mortality/rehospitalization in patients with heart failure and reduced ejection fraction. Understanding GDMT use is critical to improving clinical practice. Objectives: This study sought to describe GDMT use in Japan, Sweden, and [...]

2023-02-22T15:25:09-04:00January 1st, 2023|

Diabetes Technology: Standards of Care in Diabetes—2023

Diabetes Technology: Standards of Care in Diabetes—2023 The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary [...]

2023-02-22T14:01:16-04:00December 12th, 2022|

Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial Background: There is a paucity of evidence for dose and pace of up-titration of guideline-directed medical therapies after admission to hospital for acute heart failure. Methods: In this multinational, open-label, randomised, parallel-group trial (STRONG-HF), patients aged 18-85 [...]

2023-02-22T15:32:48-04:00December 3rd, 2022|

Results of a Remotely Delivered Hypertension and Lipid Program in More Than 10 000 Patients Across a Diverse Health Care Network

Results of a Remotely Delivered Hypertension and Lipid Program in More Than 10 000 Patients Across a Diverse Health Care Network Importance  Blood pressure (BP) and cholesterol control remain challenging. Remote care can deliver more effective care outside of traditional clinician-patient settings but scaling and ensuring access to care among diverse populations remains elusive. Objective  To implement and [...]

2023-02-22T14:08:42-04:00November 9th, 2022|

Prescribe FIT: Prescribe FIT Releases Comprehensive Report on the State of Remote Patient Monitoring Technology for Orthopedics Today

Prescribe FIT: Prescribe FIT Releases Comprehensive Report on the State of Remote Patient Monitoring Technology for Orthopedics Today A white paper from Prescribe FIT outlines the current landscape for remote monitoring, analyzing data on its ubiquity and efficacy. The white paper references a review of several studies that demonstrate remote monitoring to produce clinically [...]

2022-11-15T10:20:02-04:00October 30th, 2022|

Telemedicine management of type 2 diabetes mellitus in obese and overweight young and middle-aged patients during COVID-19 outbreak: A single-center, prospective, randomized control study

PLoS One: Telemedicine management of type 2 diabetes mellitus in obese and overweight young and middle-aged patients during COVID-19 outbreak: A single-center, prospective, randomized control study Objective: The coronavirus disease-2019 (COVID-19) pandemic severely affected the disease management of patients with chronic illnesses such as type 2 diabetes mellitus (T2DM). This study aimed to assess the effect [...]

2023-02-22T14:00:12-04:00September 29th, 2022|

Efficacy of telemedicine for the management of cardiovascular disease: a systematic review and meta-analysis

Efficacy of telemedicine for the management of cardiovascular disease: a systematic review and meta-analysis Background: Telemedicine has been increasingly integrated into chronic disease management through remote patient monitoring and consultation, particularly during the COVID-19 pandemic. We did a systematic review and meta-analysis of studies reporting effectiveness of telemedicine interventions for the management of patients with cardiovascular [...]

2023-02-22T15:29:01-04:00September 22nd, 2022|

Initial Experience with Telemedicine for Interstage Monitoring in Infants with Palliated Congenital Heart Disease

Pediatric Cardiology: Initial Experience with Telemedicine for Interstage Monitoring in Infants with Palliated Congenital Heart Disease Infants with staged surgical palliation for congenital heart disease are at high-risk for interstage morbidity and mortality. Home monitoring programs have mitigated these risks. This study examines caregivers and clinicians of the Infant Single Ventricle Monitoring Program (ISVMP). All consecutive [...]

2023-02-01T14:56:25-04:00September 11th, 2022|
Go to Top